efficacy

Health News

Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 30, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a

Read more
Wellness

Propecia vs generic

Taenia solium—also called pork tapeworm—is a parasite which causes disease around the world, particularly in very poor communities with deficient

Read more